Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

about

Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

P2860

Q47151308-2563D022-25F7-4FDA-8BAC-C2F8336359AD Q58608661-1D8D9BE1-8211-4E39-A0A7-1540445D84C8

P2860

Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

Item

http://www.wikidata.org/entity/Q36908349

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Volume matters in the systemic ...... based study in the Netherlands

@en

type

Item

label

Volume matters in the systemic ...... based study in the Netherlands

@en

prefLabel

Volume matters in the systemic ...... based study in the Netherlands

@en

P1476

Volume matters in the systemic ...... based study in the Netherlands

@en

P2093

G J M Creemers

http://www.w3.org/2001/XMLSchema#string

H W M van Laarhoven

http://www.w3.org/2001/XMLSchema#string

J W Wilmink

http://www.w3.org/2001/XMLSchema#string

M G H Besselink

http://www.w3.org/2001/XMLSchema#string

N Bernards

http://www.w3.org/2001/XMLSchema#string

N Haj Mohammad

http://www.w3.org/2001/XMLSchema#string

O R Busch

http://www.w3.org/2001/XMLSchema#string

V E P P Lemmens

http://www.w3.org/2001/XMLSchema#string

P2860

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Importance of performance status for treatment outcome in advanced pancreatic cancer.

Symptom relief and quality of life after stenting for malignant bile duct obstruction

Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.

"Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

Impact of care at comprehensive cancer centers on outcome: Results from a population-based study

Management and prognosis of pancreatic cancer over a 30-year period.

Use of chemotherapy at end of life in oncology patients.

P2888

s00432-016-2140-5

P304

1353-1360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-016-2140-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P50

Ignace Hjt de Hingh

P577

2016-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298898402

http://www.w3.org/2001/XMLSchema#string

P698

26995276

http://www.w3.org/2001/XMLSchema#string

P921

Alamad

P932

4869755

http://www.w3.org/2001/XMLSchema#string

Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

about

P2860

P2860

Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932